Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,688 | 3,629 | 6,035 | 4,604 | 5,893 |
| Depreciation Amortization | 1,294 | 1,435 | 819 | 384 | 460 |
| Income taxes - deferred | 1,736 | 377 | 697 | 660 | 1,911 |
| Accounts receivable | -1,698 | 378 | -2,287 | -1,443 | 287 |
| Accounts payable and accrued liabilities | 141 | -130 | 1,133 | -313 | 487 |
| Other Working Capital | -4,903 | -3,360 | -3,488 | -4,465 | -2,942 |
| Other Operating Activity | 2,838 | 1,078 | 1,583 | 2,574 | 356 |
| Operating Cash Flow | $3,095 | $3,407 | $4,493 | $2,001 | $6,452 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 3,500 | -3,527 | N/A | N/A |
| PPE Investments | -3,962 | -16,247 | -13,756 | -1,306 | -1,601 |
| Net Acquisitions | -16,256 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -1,000 | N/A | N/A |
| Other Investing Activity | 0 | -58 | -1,000 | 0 | 0 |
| Investing Cash Flow | $-20,218 | $-12,805 | $-18,283 | $-1,306 | $-1,601 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 16,000 | N/A | N/A | N/A |
| Debt Repayment | -1,600 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3 | 517 | 1,883 | 1,220 | 556 |
| Other Financing Activity | -47 | 170 | 643 | 506 | 0 |
| Financing Cash Flow | $-1,644 | $16,687 | $2,526 | $1,725 | $556 |
| Beginning Cash Position | 43,194 | 35,904 | 47,167 | 44,747 | 39,339 |
| End Cash Position | 24,427 | 43,194 | 35,904 | 47,167 | 44,747 |
| Net Cash Flow | $-18,767 | $7,290 | $-11,264 | $2,421 | $5,407 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,095 | 3,407 | 4,493 | 2,001 | 6,452 |
| Capital Expenditure | -3,962 | -16,247 | -13,756 | -1,306 | -1,601 |
| Free Cash Flow | -868 | -12,839 | -9,263 | 695 | 4,851 |